Search

Displaying results 5061 - 5070 of 10000 in total
  1. Drug

    Acetylcysteine zinc

    go.drugbank.com/drugs/DB14479
    Investigational

    Synonyms: N-acetyl-L-cysteine zinc saltCategories: Compounds used in a research, industrial, or household setting
  2. Drug

    Calmangafodipir

    go.drugbank.com/drugs/DB18398
    Investigational

    Synonyms: Calcium,n,n'-1,2-ethanediylbis(n-((3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycine) manganese complexes trisodium trihydrogen manganateCategories: Compounds used in a research, industrial, or household setting
  3. Drug

    Lawsone

    go.drugbank.com/drugs/DB04744
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Quinacrine mustard

    go.drugbank.com/drugs/DB02240
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Siplizumab

    go.drugbank.com/drugs/DB06371
    Investigational

  6. Drug

    Branaplam

    go.drugbank.com/drugs/DB14918
    Investigational

    Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).

  7. Drug

    Firtecan pegol

    go.drugbank.com/drugs/DB14953
    Investigational

    Firtecan pegol is under investigation in clinical trial NCT01036113 (A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer).

  8. Drug

    Rimtuzalcap

    go.drugbank.com/drugs/DB16733
    Investigational

    Rimtuzalcap is a novel modulator of small-conductance calcium-activated potassium channels that is under investigation for the treatment of essential tremor.

    Synonyms: N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine
  9. Drug

    Elinogrel

    go.drugbank.com/drugs/DB06350
    Investigational

    A P2Y12 inhibitor and platelet aggregation inhibitor.

  10. Drug

    Bremzalerbart

    go.drugbank.com/drugs/DB19417
    Investigational

    Bremzalerbart is under investigation in clinical trial NCT06602739 (A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen